SCHEMBL6981881

SCHEMBL6981881

CC(C)n1nc(-c2ccnn2-c2ccccc2)ccc1=O

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 7/20 0.43
ALDH1A1 P00352 3/20 0.39
MDM2 Q00987 1/20 0.38
POLB P06746 1/20 0.37
GAA P10253 1/20 0.37
ADORA2B P29275 1/20 0.37
MAPK14 Q16539 1/20 0.37
LMNA P02545 1/20 0.35
HTT P42858 1/20 0.35
NR3C2 P08235 1/20 0.35
CYP2C8 P10632 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C18 P33260 1/20 0.35
TSHR P16473 1/20 0.35
TP53 P04637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6987568 0.82 BMPR1B (0.35) POLBGAALMNANR3C2CYP2C8
SCHEMBL6988697 0.80 NR3C2 (0.43) PDE10AMAPK14NR3C2TP53
SCHEMBL7367730 0.80 NPBWR1 (0.39)
SCHEMBL6987355 0.79 ALDH1A1 (0.38) ALDH1A1MDM2GAATSHRTP53
SCHEMBL6986371 0.79 ALDH1A1 (0.41) ALDH1A1MDM2POLBGAAHTT
SCHEMBL7371162 0.78 PDE10A (0.43) PDE10AALDH1A1MDM2POLBADORA2B
SCHEMBL6987522 0.78 KMT2A (0.38) ALDH1A1POLBLMNA
SCHEMBL6986812 0.77 ALDH1A1 (0.40) ALDH1A1MDM2GAALMNAHTT
SCHEMBL6987843 0.76 HIF1A (0.43) ALDH1A1POLBGAALMNAHTT
SCHEMBL7369460 0.76 ADORA2B (0.47) PDE10AALDH1A1ADORA2BHTTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1313733-A1 PYRAZOLOPYRIDINE COMPOUND AND PHARMACEUTICAL USE THEREOF FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-05-28 EP disclosed
WO-2002018382-A1 PYRAZOLOPYRIDINE COMPOUND AND PHARMACEUTICAL USE THEREOF FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-03-07 WO disclosed